A black-box warning for antidepressants in children?
Newman
Thomas B
TB
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems; D026683:Advisory Committees; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003627:Data Interpretation, Statistical; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D005473:Fluoxetine / Q000627:therapeutic use; D033161:Government Regulation; D006801:Humans; D015201:Meta-Analysis as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D000092864:Suicide Prevention
D000928:Antidepressive Agents; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors